1 / 10

Trials Update

Stay informed about the latest cancer research trials, including the Add-Asprin, IROC, Pre-Empt, and PRIM studies. Learn about ongoing recruitment efforts, challenges faced, and upcoming trial deadlines.

demaree
Download Presentation

Trials Update

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Trials Update Connie ShiridzinomwaUrology Research Nurse

  2. Recruiting trials • Add-Asprin • IROC • Pre-Empt • PRIM

  3. Recruiting Trials • Add-aspirin A phase III, double-blind, placebo-controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours. • Recruiting areas, gastro, prostate and colorectal • Target 30 end of recruitment January 2021 • Recruited 24 • Recruitment challenges: Uptake decrease following media

  4. Recruiting trials • IROC • A phase III multicentre randomised controlled trial to compare the efficacy of Robotically Assisted Radical Cystectomy (RARC) and intracorporeal urinary diversion with Open Radical Cystectomy (ORC) in patients with bladder cancer • Trust target 15 end of recruitment Nov 2018 • Recruited 12 • Challenges: Large catchment area network patients not prepared to come back for follow-up visits.

  5. Recruiting Trials • Pre-EMPT: The Prostate cancer – Exercise and Metformin Trial (Pre-EMpT) is organised by the National Institute for Health Biomedical Research Centre (Nutrition), which is funded by the National Institute for Health Research and is a partnership between the University Hospitals Bristol NHS Foundation Trust and the University of Bristol. • Target 183, end date March 2020 • Recruited 6, all in surgery • Recruitment challenges: Slow up take, people already on Metformin, difficult pathway for radiotherapy and AS

  6. Recruiting trials • PRIM: Prostate Health Index (PHI)- to Refine prostate Imaging by MRI (PRIM): • Target 100, end of recruitment August 2019 • Recruited from 28 • No challenges at present

  7. Trials in follow-up • POUT (close date Dec 2021) • Boxit (close date Dec 2018) • Radicals (close date 2031) • Source (follow-up until progression) • MASTER (closing date Dec 2019)

  8. Studies in set-up • JANSSEN: Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Apalutamide in Subjects with High-risk, Localized or Locally Advanced Prostate Cancer Who are Candidates for Radical Prostatectomy • HAARP:(Newcastle) Home Assessment of urinary voiding and storage function before and After Radical Prostatectomy for prostate cancer: setting patient expectations (The HAARP study) • Neurosafe : (UCL)  A single blinded, multi‐centre, feasibility study to evaluate the ability to randomise men with prostate cancer into a trial comparing NeuroSAFE Robotic assisted radical prostatectomy (RALP) to standard Robotic assisted radical prostatectomy(RALP).

  9. Studies in set up • CamProbe: ( Cambridge)Developing a safer and simple device for local anaesthetic transperineal prostate biopsies • Gap 4  Interval: (Movember)difficulties in setting this study up include delivery of the exercise intervention, work is ongoing to try to resolve this.

  10. Thank you for your patience.

More Related